1. Home
  2. VSAT vs EVO Comparison

VSAT vs EVO Comparison

Compare VSAT & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ViaSat Inc.

VSAT

ViaSat Inc.

HOLD

Current Price

$69.52

Market Cap

9.7B

Sector

Technology

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.95

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSAT
EVO
Founded
1986
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.7B
1.1B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
VSAT
EVO
Price
$69.52
$2.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$59.80
$7.00
AVG Volume (30 Days)
2.3M
40.1K
Earning Date
05-19-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
94.42
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$5.32
$1.37
Revenue Next Year
$3.57
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.28
$2.31
52 Week High
$89.79
$4.42

Technical Indicators

Market Signals
Indicator
VSAT
EVO
Relative Strength Index (RSI) 48.21 51.17
Support Level $67.20 $2.88
Resistance Level $89.79 $3.82
Average True Range (ATR) 5.88 0.06
MACD -1.43 0.01
Stochastic Oscillator 12.60 73.17

Price Performance

Historical Comparison
VSAT
EVO

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: communication services and defense and advanced technologies. The communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers: and the defense and advanced technologies segment develops and offers a diverse array of resilient, vertically integrated solutions to government and commercial customers, leveraging core technical competencies in encryption, cyber security, tactical gateways, modems and waveforms. A large majority of the firm's revenue is generated from communication services segment.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: